Hospira Inc awarded US FDA approval of gemcitabine injection's solution version.
M2 EQUITYBITES-August 8, 2011-Hospira Inc awarded US FDA approval of gemcitabine injection's solution version(C)2011 M2 COMMUNICATIONS http://www.m2.com
Generic pharmaceuticals company Hospira Inc (NYSE:HSP) reported on Friday the receipt of approval from the US Food and Drug Administration (FDA) approval to offer gemcitabine injection in a solution formulation for the US oncology market.
The company added solution presentations include 200 mg, 1 gm and 2 gm with a concentration of 38 mg/ml.
Additionally, the company plans to unveil the gemcitabine injection in a solution formulation in early September.
According to the company, the oncology medication recorded US sales of more than USD750m in 2010, led by Eli Lilly's Gemzar.
((Comments on this story may be sent to email@example.com)).END.PUB430>PDAugust 8, 2011>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Aug 8, 2011|
|Previous Article:||-Fidelity D & D Bancorp sets USD0.25 p/s quarterly dividend.|
|Next Article:||SGOCO Group Ltd names new CFO.|